1. Approved Drugs. (2018).FDA approves tisagenlecleucel for B‐cell ALL and tocilizumab for cytokine release syndrome.https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm574154.htm(accessed 11 November 2020).
2. Press Announcements. (2018).FDA approves CAR‐T cell therapy to treat adults with certain types of large B‐cell lymphoma.https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm581216.htm(accessed 11 November 2020).
3. CARs: synthetic immunoreceptors for cancer therapy and beyond;Chang Z.L.;Trends Mol. Med.,2017
4. Chimeric antigen receptor T‐cell therapies for lymphoma;Brudno J.N.;Nat. Rev. Clin. Oncol.,2018
5. Chimeric antigen receptor T‐cell therapy – assessment
and management of toxicities;Neelapu S.S.;Nat. Rev. Clin. Oncol.,2018